RHAQ INNOVATION

Talent Strategy and Global Competitiveness

Portocanna is committed to integrating 12 Highly Qualified Human Resources (HQHR/RHAQ) to accelerate its transition into a world-class Smart Factory. This strategic plan provides the company with critical mass in key areas such as R&D, Quality Assurance, and Data Intelligence, consolidating our leadership at the forefront of the medical cannabis sector.

This investment in highly qualified human capital allows Portocanna to:

  • • Strengthen the organization’s technical and scientific capacity;
  • • Promote continuous improvement of production processes;
  • • Enhance quality, safety, and compliance standards;
  • • Bolster competitiveness in a highly regulated and growing sector.

Human Capital and Smart Specialization

The project enables the integration of senior specialists with 5 to 10 years of experience. By recruiting Masters and PhD holders in scientific and management fields, the program ensures the retention of qualified talent, aligning pharmaceutical innovation with the Regional Smart Specialization Strategy to promote territorial cohesion.

Technology, Science, and Industry 4.0

PRODUCT INNOVATION

Focus on developing highly effective therapeutic formulations and creating a high-quality portfolio for the global market.

PROCESS INNOVATION

Development of disruptive, solvent-free, and eco-friendly extraction methods that preserve biomass integrity for biocompound valorization.

PORTOCANNA SMART FACTORY:

Implementation of Industry 4.0 technologies, such as Artificial Intelligence and Data Analytics, to optimize production, logistics, and quality control.

Areas of Specialization

QUALITY AND REGULATION (QA/QP)

Rigorous EU-GMP compliance and secure batch release.

DATA AND MARKET INTELLIGENCE

Trend analysis and strategic optimization for the global market.

PRODUCTION SUPERVISION AND R&D

Technical leadership in the development of new formulations and processes.

SUPPLY CHAIN MANAGEMENT 4.0

Digitalization and full traceability across the supply chain.

PROJECT FACT SHEET AND CO-FINANCING

Project Designation: Plan for the Insertion of HQHR into the Innovation Strategies of Portocanna, S.A.

Operation Code: Application Notice ALT2030-2023-12 

Main Objective: To strengthen research, development, and business innovation capacity through the recruitment of highly qualified human resources (HQHR). 

Co-financing: Co-funded by the Alentejo Regional Program (ALENTEJO 2030).

FRAMEWORK AND PUBLIC FUNDING

Operation co-funded by the European Union through the Alentejo Regional Program – ALENTEJO 2030.

The project drives Portocanna’s competitiveness through the integration of critical mass and specialized knowledge in the medical cannabis sector. Focused on product and process innovation, the plan aims to transform the manufacturing unit into a Smart Factory based on the pillars of Industry 4.0. Through the recruitment of specialists, it promotes the development of new therapeutic formulations and the sustainable valorization of sub-products. These investments in highly qualified human capital align with the Regional Smart Specialization Strategy, fostering digital transition and operational excellence in a high-value-added pharmaceutical industry.

 

PORTOCANNA RHAQ Project

 

The realization of Portocanna‘s vision is based on acquiring critical mass to support the development of processes that promote business innovation. This project is driven by European Union co-financing through the Portugal 2030 program.

The investment channeled via ALENTEJO 2030 is fundamental to strengthening the company’s research and technological development. This support ensures the introduction of innovative methods and the launch of disruptive pharmaceutical products, consolidating our position as a global reference in the field of health and well-being.

 

Co-financed by: